ScoreWhy is Myriad Genetics, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 0.47% and Operating profit at -268.67% over the last 5 years
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -49.65%, its profits have risen by 46.8%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -49.65% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Myriad Genetics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Myriad Genetics, Inc.
-54.84%
-0.73
88.52%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.47%
EBIT Growth (5y)
-268.67%
EBIT to Interest (avg)
-34.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
1.06
Tax Ratio
20.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0.41%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.67
EV to EBIT
-5.02
EV to EBITDA
-15.22
EV to Capital Employed
0.66
EV to Sales
0.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.04%
ROE (Latest)
-9.36%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -22.6 MM
NET PROFIT(HY)
Higher at USD -13.9 MM
RAW MATERIAL COST(Y)
Fallen by -3.59% (YoY
OPERATING PROFIT(Q)
Highest at USD 1.8 MM
OPERATING PROFIT MARGIN(Q)
Highest at 0.84 %
PRE-TAX PROFIT(Q)
Highest at USD -13.9 MM
-15What is not working for the Company
ROCE(HY)
Lowest at -70.03%
INVENTORY TURNOVER RATIO(HY)
Lowest at 9.71 times
CASH AND EQV(HY)
Lowest at USD 166.2 MM
DEBT-EQUITY RATIO
(HY)
Highest at 20.66 %
INTEREST(Q)
Highest at USD 1.5 MM
EPS(Q)
Lowest at USD -3.57
Here's what is working for Myriad Genetics, Inc.
Net Profit
Higher at USD -13.9 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -13.9 MM has Grown at 73.42%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -22.6 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD 1.8 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 0.84 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -13.9 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -13.9 MM has Grown at 39.23%
over average net sales of the previous four periods of USD -22.87 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Raw Material Cost
Fallen by -3.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Myriad Genetics, Inc.
Interest
At USD 1.5 MM has Grown at 87.5%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 9.71 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Interest
Highest at USD 1.5 MM
in the last five periods and Increased by 87.5% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
EPS
Lowest at USD -3.57
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Cash and Eqv
Lowest at USD 166.2 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 20.66 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
